• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

Efficacy of fractional CO2 laser, NB-UVB and .05% clobetasol propionate vs NB-UVB and .05% clobetasol propionate in patients with vitiligo: A comparative study

    Dr Manish Choudhary, Dr Rajkumar Kothiwala

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 1027-1031

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Conventional vitiligo treatment on the hands and feet frequently yields
disappointing results. In the face, neck, and truncal areas, various ablative therapy
approaches were tested with positive results.
Material and methods: On 44 individual patients in each group with 44 pair-lesions of
non-segmental vitiligo on both hands, a prospective randomized study was done. In
(Group A) treatment with fractional CO2 laser, NB-UVB phototherapy, and 0.05 %
clobetasol propionate cream and NB-UVB phototherapy and 0.05 % clobetasol
propionate cream was given (Group B). For ten sessions, fractional CO2 laser was used
at four week intervals. NBUVB phototherapy was given twice a week for a total of 20
sessions. Twelve weeks following the last therapy, the patients were assessed. Standard
digital pictures, patient satisfaction, and adverse events were used to assess the
outcomes.
Results: Patients' satisfaction with lesions in group A was much higher than that of
group B. Lesions on dorsal surfaces of hands responded more quickly than those on
ventral surfaces.
Conclusion: In some individuals, combining fractional CO2 laser treatment with NBUVB
phototherapy and topical steroids enhances repigmentation in vitiliginous lesions
on the hands. Patients with vitiligo who have not responded to conventional therapies
may be offered this procedure.
Keywords:
    CO2 Laser Phototherapy Vitiligo
  • PDF (88 K)
  • XML
(2022). Efficacy of fractional CO2 laser, NB-UVB and .05% clobetasol propionate vs NB-UVB and .05% clobetasol propionate in patients with vitiligo: A comparative study. European Journal of Molecular & Clinical Medicine, 9(3), 1027-1031.
Dr Manish Choudhary, Dr Rajkumar Kothiwala. "Efficacy of fractional CO2 laser, NB-UVB and .05% clobetasol propionate vs NB-UVB and .05% clobetasol propionate in patients with vitiligo: A comparative study". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 1027-1031.
(2022). 'Efficacy of fractional CO2 laser, NB-UVB and .05% clobetasol propionate vs NB-UVB and .05% clobetasol propionate in patients with vitiligo: A comparative study', European Journal of Molecular & Clinical Medicine, 9(3), pp. 1027-1031.
Efficacy of fractional CO2 laser, NB-UVB and .05% clobetasol propionate vs NB-UVB and .05% clobetasol propionate in patients with vitiligo: A comparative study. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 1027-1031.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 81
  • PDF Download: 130
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus